# Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment

> **NCT02379468** · PHASE3 · COMPLETED · sponsor: **European Egyptian Pharmaceutical Industries** · enrollment: 80 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Pedyphar Ointment
- **DRUG:** Panthenol

## Key facts

- **NCT ID:** NCT02379468
- **Lead sponsor:** European Egyptian Pharmaceutical Industries
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379468, "Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02379468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*